Milestone Pharmaceuticals Inc. - Common Stock (MIST)

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / Common Stock
Shares outstanding
89,506,929
Number of holders
26
Total 13F shares, excl. options
20,148,798
Shares change
-136,076
Total reported value, excl. options
$110,818,750
Value change
-$885,245
Put/Call ratio
14.67%
Number of buys
10
Number of sells
-15
Price
$5.5

Significant Holders of Milestone Pharmaceuticals Inc. - Common Stock (MIST) as of Q2 2021

40 filings reported holding MIST - Milestone Pharmaceuticals Inc. - Common Stock as of Q2 2021.
Milestone Pharmaceuticals Inc. - Common Stock (MIST) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 20,148,798 shares of 89,506,929 outstanding shares and own 22.51% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (4,315,102 shares), ORBIMED ADVISORS LLC (2,583,821 shares), BOXER CAPITAL, LLC (2,572,194 shares), Novo Holdings A/S (2,530,585 shares), RA CAPITAL MANAGEMENT, L.P. (2,246,503 shares), Ikarian Capital, LLC (1,980,400 shares), MORGAN STANLEY (885,199 shares), SUVRETTA CAPITAL MANAGEMENT, LLC (851,291 shares), MILLENNIUM MANAGEMENT LLC (718,630 shares), and PURA VIDA INVESTMENTS, LLC (702,545 shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.